Screener
Bio-Rad Laboratories BIO Cumulative Gross Losses and Impairments
Cumulative Gross Losses and Impairments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Goodwill | $493.2 | $421.8 | $915.0 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's cumulative gross losses and impairments?
- Bio-Rad Laboratories (BIO) reported cumulative gross losses and impairments of $335.2M in Q1 2026.
- How has Bio-Rad Laboratories's cumulative gross losses and impairments changed year-over-year?
- Bio-Rad Laboratories's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $335.2M to $335.2M.
- What is the long-term trend for Bio-Rad Laboratories's cumulative gross losses and impairments?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $335.2M to $335.2M.
- What does cumulative gross losses and impairments mean?
- This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.
Ask your AI about Bio-Rad Laboratories's cumulative gross losses and impairments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude